RNA Stock Analysis: Buy, Sell, or Hold?
RNA - Avidity Biosciences, Inc. Common Stock
$13.47
0.10 (0.75%)
β²
5d:
+2.9%
30d:
-14.04%
90d:
-81.34%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When RNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
β BUY SIGNAL: RNA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
β BUY SIGNAL: RNA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: RNA is currently trading at $13.47, which is considered fair relative to its 30-day fair value range of $2.06 to $39.06.
Technical Outlook: Technically, RNA is in a strong uptrend. Immediate support is located at $11.95, while resistance sits at $13.90.
Market Sentiment: RNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.00 (+85.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RNA is in a strong uptrend. Immediate support is located at $11.95, while resistance sits at $13.90.
Market Sentiment: RNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.00 (+85.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.06 -
$39.06
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 85.6% below Wall St target ($25.00)
Fair Price Analysis
30-Day Fair Range
$2.06 -
$39.06
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$11.95
Resistance Level
$13.90
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.92
Wall Street Target
$25.00
(+85.6%)
Revenue Growth (YoY)
-71.1%
Profit Margin
-265.9%
Share & Embed Analysis
Last updated: April 02, 2026 3:56 AM ET
Data refreshes hourly during market hours. Next update: 4:56 AM
Data refreshes hourly during market hours. Next update: 4:56 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael F Maclean
SELL
4542 shares
2026-01-21
Arthur A Levin
SELL
1758 shares
2026-01-21
W. Michael Flanagan
SELL
6534 shares
2026-01-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals β¦ |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut⦠|
STRONG BUY
16 analysts |
$26 | 55 HOLD |
Advanced RNA Option Strategies
Professional options setups generated by AI based on today's RNA price and gamma walls.